China vows COVID-19 vaccine at fair, reasonable prices

BEIJING, Feb. 4 (Xinhua) — Although the cost of COVID-19 vaccines using different technical routes varies, China is committed to upholding the nature of vaccines as global public goods and providing them at fair and reasonable prices, a Foreign Ministry spokesperson said Thursday.

Spokesperson Wang Wenbin made the remarks at a press conference in response to a query on the specific arrangements and prices of the 10 million doses of COVID-19 vaccine China previously announced to provide to the COVAX initiative.

Though faced with huge domestic demand for vaccination, China is willing to work within its capacity and make efforts to turn COVID-19 vaccines into global public goods that are available and affordable to developing countries, instead of a luxury possessed by only a few countries, Wang said.

“We hope capable countries can play an active role and take concrete actions to support COVAX, so as to help developing countries receive vaccines in time and help defeat the pandemic at the earliest,” he added.

XINHUA

Xinhua News Agency, founded on November 7, 1931, is China’s national news agency as well as a global news and information network. Xinhua has set up a global news and information gathering network, with headquarters in Beijing, 33 domestic bureaus in provinces, autonomous regions and municipalities plus the special administrative regions of Hong Kong and Macao, as well as 140 bureaus in the rest of the world. Xinhua is yet to set up a bureau in Taiwan, where it has posted resident correspondents. Xinhua provides its worldwide subscribers with news and financial information products in the forms of text, photo, graphics, audio, video, and mobile phone text messages 24 hours a day in eight languages: Chinese, English, French, Russian, Spanish, Arabic, Portuguese and Japanese.